The University of Edinburgh and Cancer Research UK to conduct a trial to test use of potential virus-blocking treatment in improving COVID-19 outcomes
Research title
SPIKE-1 Trial; A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Research organisation
Researchers:
Principal Investigator:
- Professor Kev Dhaliwal, University of Edinburgh
Co-investigators:
- Prof Bruce Guthrie, The University of Edinburgh
- Prof Brian McKinstry, The University of Edinburgh
- Prof John Norrie, The University of Edinburgh
- Prof Daniel Anthony, University of Oxford
- Prof Grant Churchill, University of Oxford
- Dr Bobojon Nazarov, University of Oxford & Latus Therapeutics
- Dr Colin Ferrett, Oxford University Hospitals NHSFT
- Dr Suzie Anthony, Oxford University Hospitals NHSFT
- Dr Emma Ladds, University of Oxford, Primary Care
FULL ARTICLE HERE:
No responses yet